Literature DB >> 9930860

Remembering MOG: autoantibody mediated demyelination in multiple sclerosis?

H Wekerle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9930860     DOI: 10.1038/5514

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

1.  Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus.

Authors:  Taeg S Kim; Stanley Perlman
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

2.  Cannabinoids decrease the th17 inflammatory autoimmune phenotype.

Authors:  Ewa Kozela; Ana Juknat; Nathali Kaushansky; Neta Rimmerman; Avraham Ben-Nun; Zvi Vogel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-28       Impact factor: 4.147

3.  Effects of IFN-B on TRAIL and Decoy Receptor Expression in Different Immune Cell Populations from MS Patients with Distinct Disease Subtypes.

Authors:  Andrea L O Hebb; Craig S Moore; Virender Bhan; George S Robertson
Journal:  Autoimmune Dis       Date:  2010-12-28

4.  B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.

Authors:  Tom A Barr; Ping Shen; Sheila Brown; Vicky Lampropoulou; Toralf Roch; Sarah Lawrie; Boli Fan; Richard A O'Connor; Stephen M Anderton; Amit Bar-Or; Simon Fillatreau; David Gray
Journal:  J Exp Med       Date:  2012-04-30       Impact factor: 14.307

5.  Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination.

Authors:  Brian A Kidd; Peggy P Ho; Orr Sharpe; Xiaoyan Zhao; Beren H Tomooka; Jennifer L Kanter; Lawrence Steinman; William H Robinson
Journal:  Arthritis Res Ther       Date:  2008-09-30       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.